PRESS RELEASE published on 01/30/2025 at 18:00, 1 year ago THERANEXUS PUBLISHES ITS CASH POSITION AS OF 31 DECEMBER 2024 AND PRESENTS ITS PROGRESS REPORT Theranexus announces cash position of €4.0 M as of 29 January 2025, strengthening financial outlook. Biopharmaceutical company progressing on rare neurological disease treatments, including Niemann-Pick and Gaucher diseases Cash Position Biopharmaceutical Financial Outlook Theranexus Neurological Diseases
BRIEF published on 01/23/2025 at 18:20, 1 year ago Theranexus Unveils 2025 Financial Calendar Financial Calendar Biopharmaceutical Theranexus Neurological Diseases 2025 Schedule
PRESS RELEASE published on 01/23/2025 at 18:15, 1 year ago THERANEXUS ANNOUNCES ITS FINANCIAL CALENDAR FOR 2025 Theranexus, a biopharmaceutical company in rare neurological disease treatment, announces its 2025 financial communication agenda for Euronext market. Dates subject to change Euronext Biopharmaceutical Financial Communication Theranexus Neurological Diseases
BRIEF published on 01/23/2025 at 18:05, 1 year ago Theranexus Announces its Financial Agenda for 2025 Euronext Paris Financial Agenda Theranexus Financial Publications Neurological Diseases
BRIEF published on 01/16/2025 at 18:05, 1 year ago Theranexus: Monthly update of voting rights and shares Voting Rights Actions Stock Market Biopharmaceutical Theranexus
BRIEF published on 01/09/2025 at 18:05, 1 year ago Theranexus Publishes its Letter to Shareholders Financial Outlook Theranexus Rare Neurological Diseases Letter To Shareholders Innovative Platform
PRESS RELEASE published on 01/09/2025 at 18:00, 1 year ago THERANEXUS ANNOUNCES THE PUBLICATION OF ITS LETTER TO SHAREHOLDERS Theranexus, an innovative biopharmaceutical company, announces the publication of its letter to shareholders. Shareholders can download the newsletter from the company website Shareholders Biopharmaceutical Newsletter Theranexus Neurological Diseases
BRIEF published on 12/17/2024 at 18:20, 1 year 1 month ago Theranexus optimizes its cash flow and extends its financial horizon Treasury Funding License Agreement Theranexus Batten Disease
PRESS RELEASE published on 12/17/2024 at 18:15, 1 year 1 month ago THERANEXUS PRESENTS AN UPDATE OF ITS CASH POSITION AND FINANCING HORIZON Theranexus presents an update of its cash position and cash flow horizon, expecting improvement through upcoming payments and restructuring agreement with banking partners Cash Position Cash Flow Financial Debt Theranexus Banking Partners
BRIEF published on 12/17/2024 at 18:05, 1 year 1 month ago License agreement between Theranexus and Exeltis for TX01 Rare Diseases License Agreement Theranexus Exeltis TX01
Published on 02/07/2026 at 01:00, 1 day 7 hours ago Green Bridge Metals Can Help Secure U.S. Production of Critical Mineral Titanium
Published on 02/06/2026 at 23:10, 1 day 9 hours ago Topline Capital Management, LLC Announces Disposition of Shares of NamSys Inc.
Published on 02/06/2026 at 22:01, 1 day 10 hours ago Totec Resources Announces Listing of Shares on the Frankfurt Stock Exchange and Adoption of Omnibus Incentive Plan
Published on 02/06/2026 at 15:30, 1 day 17 hours ago Vulcan Minerals Inc. - Drilling Program Update for the Carbonear Zinc-Lead SEDEX project in Newfoundland
Published on 02/06/2026 at 13:30, 1 day 19 hours ago Redwood AI Corp. (formerly Marshall Technologies Corp.) Announces Closing of IPO and Listing of Shares on the Canadian Securities Exchange
Published on 02/07/2026 at 21:00, 11 hours 35 minutes ago Alibaba Group Debuts 'Wonder on Ice,' an Immersive AI Experience at Milan’s Sforza Castle for Milano Cortina 2026
Published on 02/07/2026 at 16:35, 16 hours ago The Ministry of Finance and the International Monetary Fund to launch tomorrow the second edition of the AlUla Conference for Emerging Market Economies
Published on 02/07/2026 at 16:20, 16 hours 15 minutes ago NOTICE OF SETTLEMENT APPROVAL HEARING - SHORT FORM - WAYLAND GROUP CORP., SCOTT LANGILLE, GERHARD MÜLLER, PAUL PATHAK, ERIC SILVER, MICHAEL STEIN, JOHN DOES 1-3, CANACCORD GENUITY CORP., AND RF SECURITIES CLEARING LP (FORMERLY KNOWN AS GMP SECU
Published on 02/06/2026 at 19:25, 1 day 13 hours ago Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 02/06/2026 at 17:52, 1 day 14 hours ago EQS-Adhoc: Avemio AG: Preparation of the filing for insolvency proceedings by Teltec AG, a subsidiary of Avemio AG, and potential effects on the going-concern assessment of Avemio AG
Published on 02/06/2026 at 18:22, 1 day 14 hours ago Disclosure of Share Capital and Voting Rights as of January 31, 2026
Published on 02/06/2026 at 16:01, 1 day 16 hours ago Notice of exercise of early redemption option of the subordinated note ISIN : FR0010093328
Published on 02/05/2026 at 18:06, 2 days 14 hours ago Aéroports de Paris SA - Shares and voting rights as of 31 January 2026
